ArticleAnnals of hematology2021

Analysis of real-world data in patients with relapsed/refractory diffuse large B cell lymphoma who received salvage chemotherapy in the rituximab era.

Shigeo Fuji et al.PubMed ↗Publisher ↗

No numbers read from the abstract.